New cancer therapy appears promising in pre-clinical trails

October 6, 2010

A new method for treating breast cancer is showing early promise in pre-clinical trials.

Researchers in the College of Science at Virginia Tech have developed molecular compounds that, when activated by laser light, have the ability to destroy without many of the side effects of most current therapies.

The research team, led by professors Karen Brewer in chemistry and Brenda Winkel in biological sciences, along with Theralase Technologies, a manufacturer of medical laser devices, has developed a way to eradicate tumors without the harmful side effects of , or a surgeon’s scalpel. The group has built what Brewer calls a molecular machine: It seeks out fast-replicating cancer cells and becomes lethal only when exposed to light.

When combined with a deep-penetrating laser from Theralase, the new molecule could help combat fast-growing cancers, such as breast, prostate, and lung, which up until now have not been able to be penetrated by light therapies.

“This research brings the potential for tremendous impact on a devastating disease, and we are excited to be working with world-class researchers at Virginia Tech to further develop this technology,”said Roger Dumoulin-White, CEO of Theralase.

The treatment recently began Phase II trials as part of a seven-year road map for Food and Drug Administration approval.

Meanwhile, Popular Mechanics has named the research and development team a Breakthrough Innovator in its sixth annual awards program. The awards recognize 10 inventors and 10 products poised to change the world in the fields of technology, medicine, aviation, and environmental engineering, among others.

“Our diverse, inspired winners are making the seemingly impossible a reality,” said James B. Meigs, editor-in-chief of the magazine. “The 2010 honorees are the people and products leading the way into the future, and we’re thrilled to recognize their advances. “

The Virginia Tech/Theralase team joins nine others in celebrating the innovator awards. Among the other inventions are soccer balls that generate light and cell phones that diagnose medical conditions.

“This recognition is truly an honor,” Brewer said. “We have been working as a team to develop more effective and less toxic cancer-fighting drugs for the past 18 years. It never ceases to amaze me what this type of team effort can accomplish.”

Brewer said the research has been assisted by students at every level, undergraduates all the way up to postdoctoral Fellows.

“This project is now an exciting example of translational research, collaborating with industry specialists, to take the promise of basic research to clinical trials and beyond.” Winkel said.

More information: Popular Mechanics, published monthly by Hearst Magazines, is read by 9 million people and engages readers with the latest innovations in science and technology. The award winners will be highlighted in the November issue, which will be on newsstands Oct. 12.

Related Stories

Recommended for you

Study suggests colon cancer cells carry bacteria with them when they metastasize

November 24, 2017
(Medical Xpress)—A team of researchers working at Harvard University has found evidence that suggests a certain type of bacteria found in colon cancer tumors makes its way to tumors in other body parts by traveling with ...

Promising new treatment for rare pregnancy cancer leads to remission in patients

November 24, 2017
An immunotherapy drug can be used to cure women of a rare type of cancer arising from pregnancy when existing treatments have failed.

Researchers unravel novel mechanism by which tumors grow resistant to radiotherapy

November 23, 2017
A Ludwig Cancer Research study has uncovered a key mechanism by which tumors develop resistance to radiation therapy and shown how such resistance might be overcome with drugs that are currently under development. The discovery ...

African Americans face highest risk for multiple myeloma yet underrepresented in research

November 23, 2017
Though African-American men are three times more likely to be diagnosed with multiple myeloma, a type of blood cancer, most scientific research on the disease has been based on people of European descent, according to a study ...

Encouraging oxygen's assault on iron may offer new way to kill lung cancer cells

November 22, 2017
Blocking the action of a key protein frees oxygen to damage iron-dependent proteins in lung and breast cancer cells, slowing their growth and making them easier to kill. This is the implication of a study led by researchers ...

One-size treatment for blood cancer probably doesn't fit all, researchers say

November 22, 2017
Though African-American men are three times more likely to be diagnosed with a blood cancer called multiple myeloma, most scientific research on the disease has been based on people of European descent, according to a study ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

not rated yet Oct 07, 2010
It's Great To Hear Their Using Lasers To Fight Cancer Cells. I Hate Cancer Side Effects! They have come a long way to avoid or reduce the side effects, but you still have to deal with the chemotherapy effects.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.